Lupin partners with LABORATORIOS ERN to launch Luforbec in Spain
Collaboration combines Lupin’s inhaler manufacturing capabilities with ERN’s strong commercial presence to expand access to respiratory care
Collaboration combines Lupin’s inhaler manufacturing capabilities with ERN’s strong commercial presence to expand access to respiratory care
Clara Sattler de Sousa e Brito to lead discovery solutions from Q3 2026, while Robert Machinek takes over as Head of Strategy & Business Development
Tomoyuki Hasegawa has been appointed CEO of FUJIFILM Biotechnologies California
The company said Wegovy hit its first one million prescriptions within 12 weeks of availability
The company said data from multiple VESPER studies show the peptide delivered meaningful weight loss, favorable tolerability, and the possibility of a first-in-class monthly injection format
Nearly 1.43 crore families in West Bengal to benefit as India’s flagship health assurance scheme achieves full national coverage across all States and Union Territories
The company has announced its entry into India’s rapidly expanding nutraceuticals and wellness sector with the launch of Neat Everyday, a new consumer wellness brand
First installation of AI-powered AMULET SOPHINITY at NM Medical aims to strengthen early breast cancer detection
Based on the cumulative data from ACHIEVE-1 through ACHIEVE-5, Lilly plans to submit orforglipron for FDA approval for the treatment of type 2 diabetes by the end of the second quarter
Subscribe To Our Newsletter & Stay Updated